Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ocular Therapeutix, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $333.1K in total
Insiders trading
5
Net value
−$333.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ocular Therapeutix, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ocular Therapeutix, Inc
NameTitleLast reported holdingLast filingFilings, past year
Notman DonaldChief Operating Officer366,529Sep 2, 20264
Kaiser PeterChief Development Officer264,378Aug 26, 20266
Nayak SanjayChief Strategy Officer326,898Aug 26, 20266
Heier Jeffrey S.Chief Scientific Officer318,326Aug 26, 20266
Dugel PravinSee Remarks744,903IndirectAug 26, 20267
Raines MerileeDirector60,933Jun 12, 20261
Lindstrom Richard L MDDirector260,933Jun 12, 20262
Graves Adrienne LDirector64,000Jun 12, 20261
Warden Charles MDirector100,464Jun 12, 20261
Williams Leslie J.Director65,433Jun 12, 20261
Hong Seung SuhDirector60,933Jun 12, 20261
Robins Jason ShandChief Financial Officer68,097Jun 12, 20262
Waheed NadiaChief Medical Officer300,079Jun 5, 20264
Robinson David WayneGlobal CCO136,000Jan 26, 20261
Anderman ToddChief Legal Officer152,468Jan 6, 20262
Saroj NamrataChief Business Officer254,620Jan 6, 20262
Meyers Steve LawrenceChief Commercial Officer217,628Jan 6, 20261
Summer Road LLC10% Owner8,591,401IndirectFeb 27, 20240
White Christopher GChief Business Officer123,689Feb 6, 20240
Mattessich Antony C.President and CEO588,701Feb 6, 20240
Ozden Rabia GursesChief Medical Officer153,054Feb 6, 20240
Strassburger Philip C.General Counsel161,493Feb 6, 20240
Goldstein Michael H.President, Ophthalmology & CMO313,335Feb 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 24, 2021 (view filing)Aug 204 daysMattessich Antony C.President and CEOPPurchase+5.00K$9.89+$49.5K+5.1%102.9K after
Dec 8, 2021 (view filing)Dec 6-82 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+60.9K$6.18+$376.6K+1.1%5.68M after2 lots
Dec 14, 2021 (view filing)Dec 10-134 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+40.5K$6.61+$267.8K+0.7%5.72M after2 lots
Dec 16, 2021 (view filing)Dec 14-152 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+44.5K$6.35+$282.3K+0.8%5.76M after2 lots
Jan 18, 2022 (view filing)Jan 13-185 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+50.0K$6.06+$303.0K+0.9%5.81M after3 lots
Jan 24, 2022 (view filing)Jan 20-244 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+74.5K$5.44+$405.6K+1.3%5.89M after3 lots
Jan 31, 2022 (view filing)Jan 27-284 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+5.50K$5.20+$28.6K+0.1%5.89M after2 lots
Feb 23, 2022 (view filing)Feb 18-235 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+50.0K$4.96+$248.0K+0.8%5.94M after2 lots
May 16, 2022 (view filing)May 124 daysHeier Jeffrey S.DirectorPPurchase+15.0K$3.05+$45.8K+62.5%39.0K after
Sep 29, 2022 (view filing)Sep 27-292 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+150.0K$4.60+$689.3K+2.5%6.09M after3 lots
Oct 12, 2022 (view filing)Oct 10-112 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+20.0K$3.95+$79.0K+0.3%6.11M after2 lots
Nov 9, 2022 (view filing)Nov 72 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+7.33K$3.50+$25.6K+0.1%6.12M after
Feb 8, 2023 (view filing)Feb 62 daysMattessich Antony C.President and CEOSSale−19.7K$4.24−$83.4K−4.2%446.3K after
Feb 8, 2023 (view filing)Feb 62 daysStrassburger Philip C.General CounselSSale−6.18K$4.24−$26.2K−5.4%109.1K after
Feb 8, 2023 (view filing)Feb 62 daysNotman DonaldChief Financial OfficerSSale−6.48K$4.24−$27.5K−4.4%139.4K after
Feb 8, 2023 (view filing)Feb 62 daysOzden Rabia GursesChief Medical OfficerSSale−6.42K$4.24−$27.2K−6.0%101.4K after
Feb 8, 2023 (view filing)Feb 62 daysWhite Christopher GChief Business OfficerSSale−5.83K$4.24−$24.7K−5.8%94.8K after
Jul 11, 2023 (view filing)Jul 74 daysOzden Rabia GursesChief Medical OfficerSSale−832$4.93−$4.10K−0.8%100.5K after
Sep 5, 2023 (view filing)Aug 306 daysLateMattessich Antony C.President and CEOPPurchase+6.50K$3.81+$24.8KNew position6.50K after
Dec 18, 2023 (view filing)Dec 144 daysSummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+1.54M$3.25+$5.00M+25.1%7.66M after
Feb 2, 2024 (view filing)Jan 312 daysMattessich Antony C.President and CEOSSale−18.3K$4.95−$90.8K−4.1%427.9K after
Feb 2, 2024 (view filing)Jan 312 daysWhite Christopher GChief Business OfficerSSale−5.15K$4.95−$25.5K−5.4%89.6K after
Feb 2, 2024 (view filing)Jan 312 daysStrassburger Philip C.General CounselSSale−6.83K$4.95−$33.8K−5.9%109.2K after
Feb 2, 2024 (view filing)Jan 312 daysOzden Rabia GursesChief Medical OfficerSSale−7.76K$4.95−$38.4K−7.7%92.8K after
Feb 2, 2024 (view filing)Jan 312 daysNotman DonaldChief Financial OfficerSSale−6.43K$4.95−$31.8K−4.4%139.9K after
Feb 6, 2024 (view filing)Feb 51 dayMattessich Antony C.President and CEOSSale+19.6K$4.86+$95.5K+3.5%588.7K after
Feb 6, 2024 (view filing)Feb 51 dayNotman DonaldChief Financial OfficerSSale+6.21K$4.86+$30.2K+3.3%195.4K after
Feb 6, 2024 (view filing)Feb 51 dayOzden Rabia GursesChief Medical OfficerSSale+6.35K$4.86+$30.8K+4.3%153.1K after
Feb 6, 2024 (view filing)Feb 51 dayStrassburger Philip C.General CounselSSale+6.03K$4.86+$29.3K+3.9%161.5K after
Feb 6, 2024 (view filing)Feb 51 dayWhite Christopher GChief Business OfficerSSale+5.91K$4.86+$28.7K+5.0%123.7K after
Feb 27, 2024 (view filing)Feb 261 daySummer Road LLC10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+930.9K$7.52+$7.00M+12.2%8.59M after
May 28, 2024 (view filing)May 235 daysDugel PravinSee RemarksSSale−21.6K$5.79−$125.2K−2.5%833.4K after10b5-1
May 28, 2024 (view filing)May 235 daysNayak SanjayChief Strategy OfficerSSale−2.27K$5.84−$13.3K−1.3%178.0K after10b5-1
Aug 27, 2024 (view filing)Aug 234 daysDugel PravinSee RemarksSSale−20.9K$9.02−$188.3K−2.5%812.5K after10b5-1
Aug 27, 2024 (view filing)Aug 234 daysNayak SanjayChief Strategy OfficerSSale−1.83K$9.02−$16.5K−1.0%176.2K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysDugel PravinSee RemarksSSale−20.7K$9.01−$186.3K−2.5%791.8K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysNayak SanjayChief Strategy OfficerSSale−1.81K$9.00−$16.3K−1.0%174.4K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysKaiser PeterChief Development OfficerSSale−2.90K$9.01−$26.1K−1.3%213.1K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysHeier Jeffrey S.Chief Scientific OfficerSSale−2.95K$9.01−$26.6K−1.1%269.1K after10b5-1
Feb 4, 2025 (view filing)Jan 31-Feb 44 daysNotman DonaldSee RemarksSSale−17.4K$7.82−$136.2K−8.3%193.4K after2 lots
Feb 26, 2025 (view filing)Feb 242 daysNayak SanjayChief Strategy OfficerSSale−1.90K$6.84−$13.0K−0.7%283.5K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysKaiser PeterChief Development OfficerSSale−3.01K$6.87−$20.7K−1.4%210.1K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.06K$6.87−$21.0K−1.1%266.0K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysDugel PravinSee RemarksSSale−21.5K$6.87−$147.5K−0.6%3.52M after10b5-1
May 12, 2025 (view filing)May 84 daysLindstrom Richard L MDDirectorPPurchase+10.0K$6.96+$69.6K+6.1%172.7K after
May 27, 2025 (view filing)May 234 daysDugel PravinSee RemarksSSale−21.2K$7.18−$152.4K−0.6%3.50M after10b5-1
May 27, 2025 (view filing)May 234 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.02K$7.18−$21.7K−1.1%263.0K after10b5-1
May 27, 2025 (view filing)May 234 daysKaiser PeterChief Development OfficerSSale−2.97K$7.17−$21.3K−1.4%207.1K after10b5-1
May 27, 2025 (view filing)May 234 daysNayak SanjayChief Strategy OfficerSSale−1.86K$7.17−$13.4K−0.7%281.6K after10b5-1
Jun 3, 2025 (view filing)Jun 21 dayWaheed NadiaChief Medical OfficerSSale−13.9K$8.05−$111.6K−6.3%206.8K after10b5-1